Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus
- PMID: 21284579
- DOI: 10.3109/10715762.2011.555765
Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus
Abstract
Increased oxidative stress and lymphocyte apoptosis are a hallmark of the autoimmune disease systemic lupus erythematosus (SLE). However, the association between oxidative stress and T lymphocytes apoptosis has still to be elucidated in SLE. In order to appraise the interaction between oxidative stress and T lymphocyte apoptosis with the severity of disease, oxidative stress profile and T lymphocytes apoptosis were studied. Increased levels of ROS, MDA and CD4(+) lymphocyte apoptosis were positively associated with disease activity while decreased levels of GSH and percentage expression of CD4(+) lymphocyte were negatively associated with disease activity. The decrease in intracellular levels of GSH was negatively associated with T lymphocyte, CD4(+) lymphocyte, CD8(+) lymphocyte apoptosis and intracellular caspase-3 expression. The present study suggests that increased T lymphocyte sub-sets apoptosis may be mediated by decreased intracellular glutathione concentration and severity of disease might be enhanced together by over-production of ROS in SLE.
Similar articles
-
Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus.Immunobiology. 2013 Apr;218(4):620-7. doi: 10.1016/j.imbio.2012.07.030. Epub 2012 Aug 4. Immunobiology. 2013. PMID: 22940256 Clinical Trial.
-
Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.Cell Immunol. 2006 Feb;239(2):121-8. doi: 10.1016/j.cellimm.2006.05.003. Epub 2006 Jun 30. Cell Immunol. 2006. PMID: 16808908
-
Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.Immunol Lett. 2010 Mar 10;129(1):7-12. doi: 10.1016/j.imlet.2010.01.005. Epub 2010 Jan 25. Immunol Lett. 2010. PMID: 20105444
-
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Arch Dermatol Res. 2009. PMID: 18985367 Review.
-
Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus.Int Rev Immunol. 2004 May-Aug;23(3-4):293-313. doi: 10.1080/08830180490452576. Int Rev Immunol. 2004. PMID: 15204090 Review.
Cited by
-
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2012 Sep;64(9):2937-46. doi: 10.1002/art.34502. Arthritis Rheum. 2012. PMID: 22549432 Free PMC article. Clinical Trial.
-
Interaction between glutathione and apoptosis in systemic lupus erythematosus.Autoimmun Rev. 2013 May;12(7):741-51. doi: 10.1016/j.autrev.2012.12.007. Epub 2012 Dec 29. Autoimmun Rev. 2013. PMID: 23279845 Free PMC article. Review.
-
A ceRNA regulatory network in systemic lupus erythematosus and its molecular interplay with cancer.Ann Transl Med. 2022 May;10(10):563. doi: 10.21037/atm-22-1533. Ann Transl Med. 2022. PMID: 35722400 Free PMC article.
-
Exploring the ROS reduction strategies in chronic lupus management.Front Immunol. 2024 Feb 20;15:1346656. doi: 10.3389/fimmu.2024.1346656. eCollection 2024. Front Immunol. 2024. PMID: 38444846 Free PMC article. No abstract available.
-
Immunometabolic disorders in the pathogenesis of systemic lupus erythematosus.Postepy Dermatol Alergol. 2019 Oct;36(5):513-518. doi: 10.5114/ada.2019.85251. Epub 2019 Nov 12. Postepy Dermatol Alergol. 2019. PMID: 31839766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials